Problem: Given the question: Question: "Which of the following are not commonly infected with malware: laptops, desktop computers, or accelerometers?"  Context: "Desktop computers and laptops are commonly infected with malware either to gather passwords or financial account information, or to construct a botnet to attack another target. Smart phones, tablet computers, smart watches, and other mobile devices such as Quantified Self devices like activity trackers have also become targets and many of these have sensors such as cameras, microphones, GPS receivers, compasses, and accelerometers which could be exploited, and may collect personal information, including sensitive health information. Wifi, Bluetooth, and cell phone network on any of these devices could be used as attack vectors, and sensors might be remotely activated after a successful breach."  Answer:
++++++++++++++++++++++++++++++++
The answer is:
accelerometers


Problem: Given the question: Question: "What is New Orleans VooDoo?"  Context: "In October 2008, Tom Benson announced that the New Orleans VooDoo were ceasing operations and folding "based on circumstances currently affecting the league and the team". Shortly thereafter, an article in Sports Business Journal announced that the AFL had a tentative agreement to sell a $100 million stake in the league to Platinum Equity; in exchange, Platinum Equity would create a centralized, single-entity business model that would streamline league and team operations and allow the league to be more profitable. Benson's move to shut down the VooDoo came during the Platinum Equity conference call, leading to speculation that he had folded because of the deal."  Answer:
++++++++++++++++++++++++++++++++
The answer is:
team


Problem: Given the question: Question: "MRSA is a bacteria known for its resistance to antibiotics, these kinds of bacteria are commonly categorized as?"  Context: "Possible improvements include clarification of clinical trial regulations by FDA. Furthermore, appropriate economic incentives could persuade pharmaceutical companies to invest in this endeavor. Antibiotic Development to Advance Patient Treatment (ADAPT) Act aims to fast track the drug development to combat the growing threat of 'superbugs'. Under this Act, FDA can approve antibiotics and antifungals treating life-threatening infections based on smaller clinical trials. The CDC will monitor the use of antibiotics and the emerging resistance, and publish the data. The FDA antibiotics labeling process, 'Susceptibility Test Interpretive Criteria for Microbial Organisms' or 'breakpoints', will provide accurate data to healthcare professionals. According to Allan Coukell, senior director for health programs at The Pew Charitable Trusts, "By allowing drug developers to rely on smaller datasets, and clarifying FDA's authority to tolerate a higher level of uncertainty for these drugs when making a risk/benefit calculation, ADAPT would make the clinical trials more feasible.""  Answer:
++++++++++++++++++++++++++++++++
The answer is:
superbugs